REDDING, Calif. , Oct. 24, 2024 /PRNewswire/ -- According to a new market research report, ' IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering (Assay Development, Packaging Development) Technology (Immunoassay, Molecular Diagnostics, Biochemistry) Application (Oncology, Diabetes) – Global Forecast to 2031, published by Meticulous Research ® The IVD assay development market is projected to reach $8.
39 billion by 2031, at a CAGR of 7.9% from 2024 to 2031. Download FREE PDF Brochure Of IVD Assay Development Market - https://www.
meticulousresearch.com/download-sample-report/cp_id=6037 In vitro diagnostics (IVD) assay development services provide comprehensive, end-to-end contracting solutions. These services include assay design and proof of concept, feasibility studies, prototype development, packaging design, stability testing, regulatory support, and more.
The assay development process involves several phases, including the selection and screening of key raw materials, preliminary feasibility assessments, optimization of assay parameters, verification of assay designs, and clinical sample testing. The growth of IVD assay development market is driven by the rising prevalence of chronic diseases & the increasing geriatric population, the high burden of infectious diseases, the growing focus on the development of POC IVD assays, and rising healthcare expenditures. However, the market growth is restrained by an evolving regulatory landscape.
More.
